Select a metric from the list below to chart it
Metric | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | LTM |
|---|---|---|---|---|---|---|
Total Revenues | 291.0 | 885.0 | 2,886.0 | 4,888.0 | 6,583.0 | 7,687.0 |
Total Revenues % Chg. | — | 204.1% | 226.1% | 69.4% | 34.7% | 36.3% |
Cost of Goods Sold, Total | 218.0 | 494.0 | 1,322.0 | 2,272.0 | 3,500.0 | 4,063.0 |
Gross Profit | 73.0 | 391.0 | 1,564.0 | 2,616.0 | 3,083.0 | 3,624.0 |
Selling General & Admin Expenses, Total | 223.0 | 863.0 | 1,547.0 | 2,471.0 | 2,845.0 | 3,123.0 |
R&D Expenses | 51.0 | 107.0 | 321.0 | 430.0 | 829.0 | 976.0 |
Depreciation & Amortization | 9.0 | 32.0 | 120.0 | 156.0 | 369.0 | 480.0 |
Other Operating Expenses, Total | 283.0 | 1,002.0 | 1,988.0 | 3,057.0 | 4,043.0 | 4,579.0 |
Operating Income | -210.0 | -611.0 | -424.0 | -441.0 | -960.0 | -955.0 |
Interest Expense, Total | -1.0 | — | -32.0 | -14.0 | -2.0 | -2.0 |
Interest And Investment Income | 7.0 | 18.0 | 7.0 | 3.0 | 32.0 | 88.0 |
Net Interest Expenses | 6.0 | 18.0 | -25.0 | -11.0 | 30.0 | 86.0 |
Currency Exchange Gains (Loss) | — | -1.0 | — | — | — | -7.0 |
Other Non Operating Income (Expenses) | — | — | 3.0 | — | 7.0 | 7.0 |
EBT, Excl. Unusual Items | -204.0 | -594.0 | -446.0 | -452.0 | -923.0 | -869.0 |
Restructuring Charges | — | — | — | — | -94.0 | -91.0 |
Merger & Related Restructuring Charges | — | -5.0 | -1.0 | -10.0 | -68.0 | -12.0 |
Gain (Loss) On Sale Of Investments | — | — | — | — | -312.0 | -312.0 |
Asset Writedown | — | — | -11.0 | -1.0 | -2.0 | -2.0 |
Other Unusual Items | — | -67.0 | — | — | — | — |
EBT, Incl. Unusual Items | -204.0 | -666.0 | -458.0 | -463.0 | -1,399.0 | -1,286.0 |
Income Tax Expense | — | 1.0 | 3.0 | 5.0 | -31.0 | -14.0 |
Earnings From Continuing Operations | -204.0 | -667.0 | -461.0 | -468.0 | -1,368.0 | -1,272.0 |
Minority Interest | — | — | — | — | 3.0 | 6.0 |
Net Income | -204.0 | -667.0 | -461.0 | -468.0 | -1,365.0 | -1,266.0 |
Preferred Dividend and Other Adjustments | 3.0 | 1.0 | — | — | — | — |
Net Income to Common Incl Extra Items | -207.0 | -668.0 | -461.0 | -468.0 | -1,365.0 | -1,266.0 |
Net Income to Common Excl. Extra Items | -207.0 | -668.0 | -461.0 | -468.0 | -1,365.0 | -1,266.0 |
Total Shares Outstanding | 41.8 | 219.7 | 318.5 | 346.5 | 391.5 | 392.7 |
Weighted Avg. Shares Outstanding | 44.3 | 43.3 | 62.4 | 336.8 | 371.4 | 387.9 |
Weighted Avg. Shares Outstanding Dil | 44.3 | 43.3 | 62.4 | 336.8 | 371.4 | 387.9 |
EPS | -4.7 | -15.4 | -7.4 | -1.4 | -3.7 | -3.3 |
EPS Diluted | -4.7 | -15.4 | -7.4 | -1.4 | -3.7 | -3.3 |
EBITDA | -204.0 | -584.0 | -321.0 | -348.0 | -748.0 | -686.0 |